Nexalis outlines 2026 plan as IRX shares jump 35% by Adam Sheldon February 17, 2026February 19, 2026 Nexalis Therapeutics Limited – formerly InhaleRx – has used its first investor presentation since formally changing […]
InhaleRx locks in A$1m cap raise and reveals plans to rebrand by Adam Sheldon December 1, 2025February 21, 2026
News in brief: Cann Group trading halt; Avecho raises $2.5m for CBD submission; IRX CEO takes shares over salary by Adam Sheldon October 23, 2025February 21, 2026
News in brief: Tilray launches pastilles; InhaleRx progresses panic disorder trial; NSW calls for hemp plan feedback; BS3 makes key hire by Steve Jones and Martin Lane April 23, 2025April 23, 2025
InhaleRx eyes big pharma deal and ponders product launch through SAS by Steve Jones March 18, 2025March 18, 2025
InhaleRx prepares for pivotal trial in quest to provide relief from breakthrough cancer pain by cannabiz team January 29, 2025January 31, 2025
News in brief: InhaleRx; Hemp Pet; Neurotech International; Cann Group by Martin Lane November 19, 2024April 11, 2025
InhaleRx secures up to $38.5m in funding for clinical trial program by Martin Lane October 18, 2024February 25, 2025
